BRIEF-Kalytera Therapeutics Q1 loss per share $0.02
May 31, 2017 at 07:11 AM EDT
* Working capital totaled $1.8 million, including cash and cash equivalents of $3.1 million, as of March 31, 2017 Source text for Eikon: Further company coverage: